A detailed history of Allegiance Financial Group Advisory Services LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Allegiance Financial Group Advisory Services LLC holds 4,720 shares of BMY stock, worth $272,249. This represents 0.08% of its overall portfolio holdings.

Number of Shares
4,720
Holding current value
$272,249
% of portfolio
0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$39.66 - $51.75 $187,195 - $244,260
4,720 New
4,720 $244 Million
Q3 2023

Oct 31, 2023

BUY
$57.89 - $64.73 $57 - $64
1 Added 0.03%
3,728 $216 Million
Q2 2023

Jul 26, 2023

BUY
$63.71 - $70.74 $63 - $70
1 Added 0.03%
3,727 $238 Million
Q4 2022

Feb 01, 2023

BUY
$68.48 - $81.09 $255,156 - $302,141
3,726 New
3,726 $268 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Allegiance Financial Group Advisory Services LLC Portfolio

Follow Allegiance Financial Group Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allegiance Financial Group Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allegiance Financial Group Advisory Services LLC with notifications on news.